Abstract: The present invention relates to: a variant polypeptide having xylanase activity; and a use thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202417011546-STATEMENT OF UNDERTAKING (FORM 3) [19-02-2024(online)].pdf | 2024-02-19 |
| 3 | 202417011546-Sequence Listing in PDF [19-02-2024(online)].pdf | 2024-02-19 |
| 4 | 202417011546-REQUEST FOR EXAMINATION (FORM-18) [19-02-2024(online)].pdf | 2024-02-19 |
| 5 | 202417011546-FORM 18 [19-02-2024(online)].pdf | 2024-02-19 |
| 6 | 202417011546-FORM 1 [19-02-2024(online)].pdf | 2024-02-19 |
| 7 | 202417011546-DRAWINGS [19-02-2024(online)].pdf | 2024-02-19 |
| 8 | 202417011546-DECLARATION OF INVENTORSHIP (FORM 5) [19-02-2024(online)].pdf | 2024-02-19 |
| 9 | 202417011546-COMPLETE SPECIFICATION [19-02-2024(online)].pdf | 2024-02-19 |
| 10 | 202417011546-certified copy of translation [21-02-2024(online)].pdf | 2024-02-21 |
| 11 | 202417011546-Certified Copy of Priority Document [15-04-2024(online)].pdf | 2024-04-15 |
| 12 | 202417011546-Proof of Right [21-04-2024(online)].pdf | 2024-04-21 |
| 13 | 202417011546-FORM-26 [21-04-2024(online)].pdf | 2024-04-21 |
| 14 | 202417011546-FORM 3 [08-07-2024(online)].pdf | 2024-07-08 |